XOMA Royalty (XOMA) Intangibles (2022 - 2026)
XOMA Royalty (XOMA) reported Intangibles of $43.9 million for Q1 2026, up 72.93% on a YoY basis from $25.4 million in Q1 2025, and down 1.99% sequentially from $44.8 million in Q4 2025.
XOMA Royalty (XOMA) Intangibles (2022 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 5 years of Intangibles data on file, last reported at $43.9 million in Q1 2026.
- For the quarter ending Q1 2026, Intangibles rose 72.93% year-over-year to $43.9 million; the trailing twelve-month figure through Mar 2026 stood at $43.9 million (up 72.93% YoY), and the FY2025 full-year result was $44.8 million, up 72.74% from the prior year.
- Intangibles slipped to $43.9 million in Q1 2026, from $44.8 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $45.4 million in Q2 2025 to a low of $14.5 million in Q3 2023.
- A 5-year average of $26.0 million and a median of $20.3 million in 2023 frame the typical range for Intangibles.
- Across the five-year window, Intangibles gained 0.64% in 2023 and jumped 72.93% in 2026, its largest moves.
- Tracing XOMA's Intangibles over 5 years: stood at $15.2 million in 2022, then increased by 0.64% to $15.2 million in 2023, then soared by 69.93% to $25.9 million in 2024, then surged by 72.74% to $44.8 million in 2025, then slipped by 1.99% to $43.9 million in 2026.
- Business Quant data shows XOMA's Intangibles at $43.9 million in Q1 2026, $44.8 million in Q4 2025, and $45.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 43.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.86 Mn |
| Dec 31, 2025 | 44.76 Mn |
| Jun 30, 2025 | 45.43 Mn |
| Mar 31, 2025 | 25.37 Mn |
| Dec 31, 2024 | 25.91 Mn |
| Dec 31, 2023 | 15.25 Mn |
| Sep 30, 2023 | 14.48 Mn |
| Jun 30, 2023 | 14.70 Mn |
| Mar 31, 2023 | 14.93 Mn |
| Dec 31, 2022 | 15.15 Mn |